Real-world data on systemic treatment and biomarker testing in patients with advanced or metastatic endometrial cancer: results from the German registry platform SMARAGD 25. Oktober 2024 Gratzke K., Decker T., Juhasz-Böss I., Zaiss M., Papathemelis T., Flade F., Haus A., Jaenicke M., Winter S., Georganoudis N., Marschner N., Stickeler E., Welt A., Watermann D. , Wöckel A.; 2024, Posternumber P349 Download Real world data on pathological complete remission after neoadjuvant therapy with or without anthracyclines in patients with HER2-positive breast cancer – data from the registry platform OPAL Zahn M.-O. , Decker T. , Stickeler E. , Zaiss M. , Fietz T. , Nusch A. , Peters N. , Wende C. , Beurer… Weiterlesen Patients with multiple myeloma – What happens in second line after first-line refractory to daratumumab? Data from the German MYRIAM registry Nusch, A., Burkhard-Meier, U., Jacobasch, L., Linde, H., Uhlig, J., Welslau, M., Tech, S., Medinger, T., Jänicke, M., Dechow, T., Einsele, H., Engelhardt, M., Knauf,… Weiterlesen